Travoprost ophthalmic solution, 0.001%

DRUG2 trials

Sponsors

Alcon Research

Conditions

Ocular HypertensionOpen-angle Glaucoma

Phase 2

Safety and Intraocular Pressure (IOP) Lowering Efficacy of Low Dose Travoprost

CompletedNCT00637130

Alcon ResearchOcular Hypertension, Open-angle Glaucoma

Start: 2007-10-31Updated: 2012-12-06

Divided Dose of TRAVATAN®

CompletedNCT01298687

Alcon ResearchOcular Hypertension, Open-angle Glaucoma

Start: 2011-02-28End: 2011-04-30Updated: 2017-05-05